# Clinical Study of 18F-Alfatide Injection PET/CT

> **NCT06416852** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Yantai LNC Biotechnology Singapore PTE. LTD.** · enrollment: 428 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer NSCLC

## Interventions

- **DRUG:** 18F-Alfatide Injection
- **DRUG:** 18F-FDG Injection

## Key facts

- **NCT ID:** NCT06416852
- **Lead sponsor:** Yantai LNC Biotechnology Singapore PTE. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 428 (ESTIMATED)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06416852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06416852, "Clinical Study of 18F-Alfatide Injection PET/CT". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06416852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*